tiprankstipranks
Advertisement
Advertisement
Gyre Therapeutics to acquire Cullgen in $300M all-stock transaction
PremiumThe FlyGyre Therapeutics to acquire Cullgen in $300M all-stock transaction
1M ago
Pulmatrix announces Cullgen terminates merger agreement
Premium
The Fly
Pulmatrix announces Cullgen terminates merger agreement
1M ago
Pulmatrix and Cullgen Suspend No-Solicitation to Seek Alternatives
Premium
Company Announcements
Pulmatrix and Cullgen Suspend No-Solicitation to Seek Alternatives
4M ago
Pulmatrix Reports Q2 2025 Results and Merger Plans
PremiumCompany AnnouncementsPulmatrix Reports Q2 2025 Results and Merger Plans
7M ago
Pulmatrix to potentially divest its patent portfolio for iSPERSE technology
Premium
The Fly
Pulmatrix to potentially divest its patent portfolio for iSPERSE technology
8M ago
Pulmatrix trading resumes
Premium
The Fly
Pulmatrix trading resumes
10M ago
Pulmatrix Reports 2024 Financials and Merger Plans
PremiumCompany AnnouncementsPulmatrix Reports 2024 Financials and Merger Plans
1y ago
Cullgen begins Phase 1 dosing of oral, pan-TRK protein degrader
Premium
The Fly
Cullgen begins Phase 1 dosing of oral, pan-TRK protein degrader
1y ago
Pulmatrix trading resumes
Premium
The Fly
Pulmatrix trading resumes
1y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100